← Browse by Condition
Medical Condition

chickenpox

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 3
NCT06806137 Phase 3
Recruiting

A Study on the Immune Response and Safety of the Second Dose of an Investigational Chickenpox Vaccine When Given to Healthy Children 3 Months After a First Dose at 12 to 15 Months of Age

Enrollment
600 pts
Location
Dominican Republic
Sponsor
GlaxoSmithKline
View Trial →